The OCR profile shows that T cells from mice treated with both IL-12 and OX40 antibody, compared with other treatment groups, contain spare respiratory capacity (maximal respiration − basal) that can correlate with an enhanced anti-tumor response. This evidence concerns the gene TNFRSF4 and neoplasm.